NewAllergy & Cognitive Neuroscience 29 June 2026 Dihexa for Hay Fever & Antihistamine Brain Fog: Allergic Rhinitis, Histamine, the Anticholinergic-Dementia Link & the 2026 UK Review Around 16 million people in the UK have hay fever and hay fever brain fog has two sources: the allergy and the medicine
KPV : 69630-60-0 Testing & Quality Assurance Testing & Quality Assurance Trust starts with transparency
Reduction in Appetite and Caloric Intake: By affecting hunger hormones and gastric emptying, GLP-1 can help reduce appetite and caloric intake, leading to weight loss
Acute Care Open 3 , e000219 (2018)
We focus on your long-term health not quick fixes
Medical science has made such tremendous progress that there is hardly a healthy human left. Aldous Huxley GLP-1 Agonists at a Glance First-Generation (Short-Acting) Exenatide Byetta Lixisenatide Adlyxin / Lyxumia Second-Generation (Long-Acting) Exenatide ER Bydureon (weekly, now discontinued in some markets) Liraglutide Victoza (diabetes), Saxenda (obesity) Dulaglutide Trulicity Semaglutide Ozempic (diabetes), Wegovy (obesity), Rybelsus (oral) Dual Agonist (GIP + GLP-1) Tirzepatide Mounjaro (diabetes), Zepbound (obesity) Triple or Combination Agonists (In Development) Retatrutide Triple agonist (GLP-1 + GIP + glucagon) CagriSema Combination of cagrilintide + semaglutide (GLP-1 + amylin analog) Orforglipron Oral, non-peptide GLP-1 receptor agonist (Eli Lilly) Danuglipron Oral small-molecule GLP-1 agonist (Pfizer) Efinopegdutide GLP-1/glucagon dual agonist (Merck/Biocon) AMG133 GLP-1 + GIP receptor modulator (Amgen)